Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 2-3
Total Joint Arthroplasty or Trapeziectomy for Treating Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 2 and 3: a Randomized Clinical Trial
1 other identifier
interventional
62
1 country
1
Brief Summary
Trapeziometacarpal osteoarthritis is a common cause of pain and loss of hand function in postmenopausal women. Many surgical treatments have been described and recent literature has show that the relatively simple trapeziectomy gives equal results and less complications, when compared to other techniques such as ligament reconstructions and interpositions. A relatively new treatment modality, which has been further developed in recent years is the total joint arthroplasty. Randomized prospective trials and long-term results are lacking, but prospective cohorts show a faster recovery and good results after one year, without an increase in complication rate. We hypothesize that a total joint arthroplasty gives a better objective and subjective result after one year than a trapeziectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2014
CompletedFirst Posted
Study publicly available on registry
July 30, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedSeptember 5, 2016
September 1, 2016
3 years
July 29, 2014
September 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Michigan Hand Outcomes Questionnaire (MHOQ)
Is there a difference is daily hand function between patients with a total joint arthroplasty and patients with a trapeziectomy after 1 year postoperatively, measured with the total score of the Michigan Hand Outcomes Questionnaire (MHOQ)?
1 year after surgery
Secondary Outcomes (7)
Michigan Hand Outcomes Questionnaire (MHOQ)
5 years after surgery
Michigan Hand Outcomes Questionnaire (MHOQ)
1 and 5 years after surgery
Disabilities of Arm Shoulder and Hand (DASH)
1 and 5 years after surgery
Grip strength
1 and 5 years after surgery
Thumb mobility
1 and 5 years after surgery
- +2 more secondary outcomes
Study Arms (2)
Total Joint Arthroplasty
ACTIVE COMPARATORTotal Joint Arthroplasty
Trapeziectomy
ACTIVE COMPARATORTrapeziectomy
Interventions
Total Joint Arthroplasty with device: Maïa® trapezio-metacarpal joint prosthesis, Groupe Lépine, Genay, France
Eligibility Criteria
You may qualify if:
- Women.
- years of age or more.
- Symptomatic trapeziometacarpal osteoarthritis.
- Eaton \& Glickel stage 2 and 3.
You may not qualify if:
- An operation for trapeziometacarpal osteoarthritis on the same hand in the past.
- Participation in randomized clinical trial for trapeziometacarpal osteoarthritis with contralateral hand.
- Secondary trapeziometacarpal osteoarthritis as result of trauma, rheumatoid arthritis, systemic lupus or gout.
- Symptomatic carpal tunnel syndrome in same hand.
- Symptomatic Quervain's tenosynovitis in same hand.
- Neurological or other disorders of the affected side that can influence postoperative rehabilitation.
- Insufficient knowledge of Dutch language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Isalalead
Study Sites (1)
Isala Hospital
Zwolle, Overijssel, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jeroen H. van Uchelen, MD
Isala
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 29, 2014
First Posted
July 30, 2014
Study Start
September 1, 2014
Primary Completion
September 1, 2017
Study Completion
September 1, 2021
Last Updated
September 5, 2016
Record last verified: 2016-09